Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of interferon signaling

The present invention provides a compound of Formula I:wherein R isor a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes.

Saved in:
Bibliographic Details
Main Authors Jessop, Theodore Curtis, Chen, Zhaogen, Bleisch, Thomas John
Format Patent
LanguageEnglish
Published 25.04.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a compound of Formula I:wherein R isor a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes.
Bibliography:Application Number: US202117168399